<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <sponsors>
      <item>
        <firstName>H.</firstName>
        <middleName>Morgan</middleName>
        <district>9</district>
        <lastName>Griffith</lastName>
        <fullName>Rep. Griffith, H. Morgan [R-VA-9]</fullName>
        <state>VA</state>
        <identifiers>
          <bioguideId>G000568</bioguideId>
          <lisID>2070</lisID>
          <gpoId>8200</gpoId>
        </identifiers>
        <bioguideId>G000568</bioguideId>
        <party>R</party>
        <byRequestType />
      </item>
    </sponsors>
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-115hr1703ih/xml/BILLS-115hr1703ih.xml</url>
          </item>
        </formats>
        <date>2017-03-23T04:00:00Z</date>
      </item>
    </textVersions>
    <updateDate>2019-04-18T16:05:25Z</updateDate>
    <congress>115</congress>
    <billNumber>1703</billNumber>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <summaries>
      <billSummaries>
        <item>
          <versionCode>00</versionCode>
          <actionDate>2017-03-23</actionDate>
          <name>Introduced in House</name>
          <actionDesc>Introduced in House</actionDesc>
          <lastSummaryUpdateDate>2018-06-27T13:37:04Z</lastSummaryUpdateDate>
          <text><![CDATA[<p><b>Medical Product Communications Act of 2017</b></p> <p>This bill amends the Federal Food, Drug, and Cosmetic Act to state that the intended use of a drug, biological product, or device shall be determined by the objective intent of the manufacturer and sponsor of such drug, biological product, or device, as demonstrated by statements contained in labeling, advertising, or analogous oral statements.</p> <p>The intended use of these medical products shall not be determined by actual or constructive knowledge of the manufacturer or sponsor that these products will be used in a manner that varies from the use approved for marketing.</p> <p>Additionally, the scientific exchange of information about these products shall not constitute labeling, advertising, or evidence of a new intended use.The bill sets forth the requirements for a scientific exchange.</p>]]></text>
          <updateDate>2017-03-23T04:00:00Z</updateDate>
        </item>
      </billSummaries>
    </summaries>
    <billType>HR</billType>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 163, Number 51 (Thursday, March 23, 2017)]From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Mr. GRIFFITH:H.R. 1703.Congress has the power to enact this legislation pursuantto the following:This bill is enacted pursuant to the power granted toCongress under Article I, Section 8 of the United StatesConstitution.[Page H2370]</pre>]]></constitutionalAuthorityStatementText>
    <originChamber>House</originChamber>
    <amendments />
    <committees>
      <billCommittees>
        <item>
          <chamber>House</chamber>
          <type>Standing</type>
          <name>Energy and Commerce Committee</name>
          <subcommittees>
            <item>
              <activities>
                <item>
                  <name>Referred to</name>
                  <date>2017-03-24T13:13:15Z</date>
                </item>
              </activities>
              <name>Health Subcommittee</name>
              <systemCode>hsif14</systemCode>
            </item>
          </subcommittees>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2017-03-23T13:03:15Z</date>
            </item>
          </activities>
          <systemCode>hsif00</systemCode>
        </item>
      </billCommittees>
    </committees>
    <laws />
    <calendarNumbers />
    <cosponsors>
      <item>
        <party>R</party>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <firstName>Gus</firstName>
        <state>FL</state>
        <lastName>Bilirakis</lastName>
        <middleName>M.</middleName>
        <sponsorshipWithdrawnDate />
        <district>12</district>
        <bioguideId>B001257</bioguideId>
        <sponsorshipDate>2017-06-02</sponsorshipDate>
        <identifiers>
          <lisID>1838</lisID>
          <bioguideId>B001257</bioguideId>
          <gpoId>7881</gpoId>
        </identifiers>
        <fullName>Rep. Bilirakis, Gus M. [R-FL-12]</fullName>
      </item>
    </cosponsors>
    <actions>
      <actionByCounts>
        <houseOfRepresentatives>4</houseOfRepresentatives>
      </actionByCounts>
      <item>
        <actionDate>2017-03-24</actionDate>
        <committee>
          <systemCode>hsif14</systemCode>
          <name>Health Subcommittee</name>
        </committee>
        <links />
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
        <actionDate>2017-03-23</actionDate>
        <links />
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <type>IntroReferral</type>
      </item>
      <item>
        <text>Introduced in House</text>
        <committee />
        <actionDate>2017-03-23</actionDate>
        <links />
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <type>IntroReferral</type>
      </item>
      <item>
        <text>Introduced in House</text>
        <committee />
        <actionDate>2017-03-23</actionDate>
        <links />
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <type>IntroReferral</type>
      </item>
      <actionTypeCounts>
        <billReferrals>1</billReferrals>
        <introducedInTheHouse>1</introducedInTheHouse>
        <introducedInHouse>1</introducedInHouse>
        <placeholderTextForH>1</placeholderTextForH>
      </actionTypeCounts>
    </actions>
    <cboCostEstimates />
    <titles>
      <item>
        <parentTitleType />
        <titleType>Official Title as Introduced</titleType>
        <chamberCode />
        <title>To amend the Federal Food, Drug, and Cosmetic Act with respect to determining the intended use of drugs and devices.</title>
        <chamberName />
      </item>
      <item>
        <parentTitleType />
        <titleType>Short Titles as Introduced</titleType>
        <chamberCode />
        <title>Medical Product Communications Act of 2017</title>
        <chamberName />
      </item>
      <item>
        <parentTitleType />
        <titleType>Display Title</titleType>
        <chamberCode />
        <title>Medical Product Communications Act of 2017</title>
        <chamberName />
      </item>
      <item>
        <parentTitleType />
        <titleType>(Extracted from GPO) Short Titles as Introduced</titleType>
        <chamberCode />
        <title>Medical Product Communications Act of 2017</title>
        <chamberName />
      </item>
    </titles>
    <introducedDate>2017-03-23</introducedDate>
    <title>Medical Product Communications Act of 2017</title>
    <latestAction>
      <actionDate>2017-03-24</actionDate>
      <text>Referred to the Subcommittee on Health.</text>
      <links />
    </latestAction>
    <recordedVotes />
    <subjects>
      <billSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
        <legislativeSubjects>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Scientific communication</name>
          </item>
        </legislativeSubjects>
      </billSubjects>
    </subjects>
    <committeeReports />
    <notes />
    <relatedBills />
    <version>1.0.0</version>
    <createDate>2017-03-24T05:20:59Z</createDate>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

